ENTROPY NEURODYNAMIC ORDINARY (ENP) Short Interest
ENTROPY NEURODYNAMIC ORDINARY (ASX:ENP) had 0.00% of shares reported as short positions as of 16 July 2026, representing 6 shares. ENTROPY NEURODYNAMIC ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Entropy Neurodynamics
Entropy Neurodynamics is an Australian biotechnology company focused on developing novel therapies for neurological and psychiatric disorders. They leverage innovative approaches in drug development, aiming to address unmet needs in mental health and improve patient outcomes. The company is listed on the ASX and seeks to create value through its research and development pipeline.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ENP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Entropy Neurodynamics
Latest ENP news
All news- Long Shortz with Entropy Neurodynamics: Phase Two results exceed expectations
stockhead
- Additional Australian patent granted
asx
- Investor Presentation
asx
- Entropy Neurodynamics (ASX:ENP): Could These World-First IV Psilocin Results Be Breakthrough Moment? - Kalkine
googlenews
- 100% Clinical improvement, 50% Remission in BED study
asx
About
website
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ENP
Start a research thread or post the first pulse update